KURT VON EMSTER
CIK 1252524 · last filed 2025-07-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$362.70M
Companies
8
Total Filings
100
Lifetime Open-Market Net
-$64.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JSPRW | Director | 21,175 | $0.01 | $284 | -$13.5K | 6 | 2025-07-03 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | 18,406 | $32.48 | $597.8K | -$19.00M | 30 | 2024-03-22 |
| PCVX | Director | 4,168,718 | $47.46 | $197.85M | $200.0K | 4 | 2021-06-03 |
| VERA | Director | 2,978,059 | $34.26 | $102.03M | $8.71M | 2 | 2021-05-18 |
| CRSP | Director | 1,261,268 | $49.80 | $62.81M | -$39.41M | 6 | 2019-01-18 |
| CRISPR Therapeutics AG (PZRX) Delisted | Director | 1,887,202 | — | — | -$12.92M | 24 | 2018-01-11 |
| Pernix Sleep, Inc. (SOMX) Delisted | Director | 30,893 | — | — | -$1.74M | 23 | 2013-01-03 |
| FACT | Director | 1,667 | $10.65 | $17.8K | $0 | 3 | 2010-04-21 |
Recent Filings · Page 7 of 10
100 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-08-02 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −5,512 | -$96.5K | EDGAR |
| 2017-07-31 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −41,312 | -$728.1K | EDGAR |
| 2017-07-27 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −32,930 | -$579.5K | EDGAR |
| 2017-07-17 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −69,859 | -$1.18M | EDGAR |
| 2017-07-13 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −31,992 | -$529.9K | EDGAR |
| 2017-07-07 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −4,254 | -$69.2K | EDGAR |
| 2017-06-30 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −43,202 | -$730.1K | EDGAR |
| 2017-06-28 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −81,435 | -$1.39M | EDGAR |
| 2017-06-26 | CRISPR Therapeutics AG (PZRX) Delisted | Sell (S) | −32,368 | -$525.3K | EDGAR |
| 2017-06-02 | CRISPR Therapeutics AG (PZRX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.